Patient Preferences Regarding Side Effects of Chemotherapy for Ovarian Cancer: Do They Change over Time?

Author： Sun C.C. Bodurka D.C. Donato M.L. Rubenstein E.B. Borden C.L. Basen-Engquist K. Munsell M.F. Kavanagh J.J. Gershenson D.M.

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.87, Iss.1, 2002-10, pp. : 118-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient preferences regarding recontact by cancer genetics clinicians

By Griffin Constance Axilbund Jennifer Codori Ann Deise Ginny May Betty Pendergrass Cheryl Tillery Miriam Trimbath Jill Giardiello Francis

Familial Cancer, Vol. 6, Iss. 3, 2007-09 ,pp. : 265-273

Springer Publishing Company

Access to resources Recommend Favorite

Clinical study of Shenqi Fuzheng injection decreasing side-effects of chemotherapy for patients with ovarian epithelial cancer

By Zhang Yu Wan Jing Yang Yuebo Li Xiaomao

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 537-539

Springer Publishing Company

Access to resources Recommend Favorite

A Systematic Overview of Chemotherapy Effects in Ovarian Cancer

By Högberg Thomas Glimelius Bengt Nygren Peter

Acta Oncologica, Vol. 40, Iss. 2-3, 2001-03 ,pp. : 340-360

Informa Healthcare

Access to resources Recommend Favorite

Patient versus clinician preferences for chemotherapy in non-small-cell lung cancer

By Long Anne Ferraro Danielle Stockler Martin Blinman Prunella

Lung Cancer Management, Vol. 2, Iss. 6, 2013-12 ,pp. : 527-536

Future Medicine

Access to resources Recommend Favorite

Paclitaxel and Carboplatin Combination Chemotherapy in a Hemodialysis Patient with Advanced Ovarian Cancer

By Watanabe M. Aoki Y. Tomita M. Sato T. Takaki Y. Kato N. Kikuchi M. Kase H. Tanaka K.

Gynecologic Oncology, Vol. 84, Iss. 2, 2002-02 ,pp. : 335-338

Elsevier

Access to resources Recommend Favorite